Cited by 144

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease

Chen, Shuo, Chang, Yuzhou, Li, Liangping, Acosta, Diana, Li, Yang, Guo, Qi, Wang, Cankun, Turkes, Emir, Morrison, Cody, Julian, Dominic, Hester, Mark E., Scharre, Douglas W., Santiskulvong, Chintda, Song, Sarah XueYing, Plummer, Jasmine T., Serrano, Geidy E., Beach, Thomas G., Duff, Karen E., Ma, Qin, Fu, Hongjun·2022·Acta Neuropathologica Communications

Published version of a preprint

Abstract

Human middle temporal gyrus (MTG) is a vulnerable brain region in early Alzheimer’s disease (AD), but little is known about the molecular mechanisms underlying this regional vulnerability. Here we utilize the 10 × Visium platform to define the spatial transcriptomic profile in both AD and control (CT) MTG. We identify unique marker genes for cortical layers and the white matter, and layer-specific differentially expressed genes (DEGs) in human AD compared to CT. Deconvolution of the Visium spots showcases the significant difference in particular cell types among cortical layers and the white matter. Gene co-expression analyses reveal eight gene modules, four of which have significantly altered co-expression patterns in the presence of AD pathology. The co-expression patterns of hub genes and enriched pathways in the presence of AD pathology indicate an important role of cell–cell-communications among microglia, oligodendrocytes, astrocytes, and neurons, which may contribute to the cellular and regional vulnerability in early AD. Using single-molecule fluorescent in situ hybridization, we validated the cell-type-specific expression of three novel DEGs (e.g., KIF5A , PAQR6 , and SLC1A3 ) and eleven previously reported DEGs associated with AD pathology (i.e., amyloid beta plaques and intraneuronal neurofibrillary tangles or neuropil threads) at the single cell level. Our results may contribute to the understanding of the complex architecture and neuronal and glial response to AD pathology of this vulnerable brain region.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-022-01494-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 31 references

Research works printed but not linked: 47

  1. Wu YT, Beiser AS, Breteler MMB, Fratiglioni L, Helmer C, Hendrie HC et al (2017) The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 13:327–339 · DOI · Paper page
  2. Butt AM, De La Rocha IC, Rivera A (2019) Oligodendroglial cells in Alzheimer’s disease. Adv Exp Med Biol 1175:325–333 · DOI
  3. Kenigsbuch M, Bost P, Halevi S, Chang Y, Chen S, Ma Q et al (2022) A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat Neurosci 25:876–886 · DOI · Paper page
  4. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800 · DOI · Paper page
  5. Leng K, Li E, Eser R, Piergies A, Sit R, Tan M et al (2021) Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease. Nat Neurosci 24:276–287 · DOI · Paper page
  6. Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ et al (2019) Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 570:332–337 · DOI · Paper page
  7. Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M et al (2019) A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci 22:47–56 · DOI · Paper page
  8. Navarro JF, Croteau DL, Jurek A, Andrusivova Z, Yang B, Wang Y et al (2020) Spatial transcriptomics reveals genes associated with dysregulated mitochondrial functions and stress signaling in Alzheimer disease. Science 23:1056
  9. Pasquini L, Rahmani F, Maleki-Balajoo S, La Joie R, Zarei M, Sorg C et al (2019) Medial temporal lobe disconnection and hyperexcitability across Alzheimer’s disease stages. J Alzheimers Dis Rep 3:103–112 · DOI
  10. Brokaw DL, Piras IS, Mastroeni D, Weisenberger DJ, Nolz J, Delvaux E et al (2020) Cell death and survival pathways in Alzheimer’s disease: an integrative hypothesis testing approach utilizing -omic data sets. Neurobiol Aging 95:15–25 · DOI
  11. Piras IS, Krate J, Delvaux E, Nolz J, Mastroeni DF, Persico AM et al (2019) Transcriptome changes in the Alzheimer’s disease middle temporal gyrus: importance of RNA metabolism and mitochondria-associated membrane genes. J Alzheimers Dis 70:691–713 · DOI
  12. Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H et al (2021) White matter aging drives microglial diversity. Neuron 109(1100–1117):e1110
  13. Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L et al (2020) Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26:769–780 · DOI · Paper page
  14. Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG et al (2015) Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology 35:354–389 · DOI · Paper page
  15. Vonsattel JP, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 115:509–532 · DOI
  16. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd et al (2019) Comprehensive integration of single-cell data. Cell 177(1888–1902):e1821
  17. Maynard KR, Collado-Torres L, Weber LM, Uytingco C, Barry BK, Williams SR et al (2021) Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex. Nat Neurosci 24:425–436 · DOI · Paper page
  18. Orehek A, Iglesias-Rozas JR, Garrosa MJAaS (2019) Architectural Arrangement of Neurons as Part of the Functional Unit of the Central Nervous System · DOI
  19. Langfelder P, Horvath S (2012) Fast R functions for Robust correlations and hierarchical clustering. J Stat Softw 46:1 · DOI
  20. Hagen MD, Kassirer JP, Kopelman RI (1989) Tripping over technology. Hosp Pract (Off Ed) 24(25–28):33–25
  21. Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284–287 · DOI · Paper page
  22. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F et al (2009) Uniquely hominid features of adult human astrocytes. J Neurosci 29:3276–3287 · DOI · Paper page
  23. Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29:547–553 · DOI · Paper page
  24. O’Leary LA, Davoli MA, Belliveau C, Tanti A, Ma JC, Farmer WT et al (2020) Characterization of vimentin-immunoreactive astrocytes in the human brain. Front Neuroanat 14:31 · DOI
  25. Hofmann K, Rodriguez-Rodriguez R, Gaebler A, Casals N, Scheller A, Kuerschner L (2017) Astrocytes and oligodendrocytes in grey and white matter regions of the brain metabolize fatty acids. Sci Rep 7:10779 · DOI
  26. Garcia-Cabezas MA, Zikopoulos B, Barbas H (2019) The Structural Model: a theory linking connections, plasticity, pathology, development and evolution of the cerebral cortex. Brain Struct Funct 224:985–1008 · DOI
  27. Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A 82:4531–4534 · DOI · Paper page
  28. Chung NC, Miasojedow B, Startek M, Gambin A (2019) Jaccard/Tanimoto similarity test and estimation methods for biological presence-absence data. BMC Bioinf 20:644 · DOI
  29. Andersson A, Bergenstrahle J, Asp M, Bergenstrahle L, Jurek A, Fernandez Navarro J et al (2020) Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography. Commun Biol 3:565 · DOI
  30. Li B, Zhang W, Guo C, Xu H, Li L, Fang M et al (2022) Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution. Nat Methods 19:662–670 · DOI · Paper page
  31. Kleshchevnikov V, Shmatko A, Dann E, Aivazidis A, King HW, Li T et al (2022) Cell 2location maps fine-grained cell types in spatial transcriptomics. Nat Biotechnol 40:661–671 · DOI · Paper page
  32. Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al (2000) Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733–748 · DOI · Paper page
  33. Langseth CM, Gyllborg D, Miller JA, Close JL, Long B, Lein ES et al (2021) Comprehensive in situ mapping of human cortical transcriptomic cell types. Commun Biol 4:998 · DOI
  34. Otero-Garcia M, Xue Y-Q, Shakouri T, Deng Y, Morabito S, Allison T, et al (2020) Single-soma transcriptomics of tangle-bearing neurons in Alzheimer’s disease reveals the signatures of tau-associated synaptic dysfunction · DOI
  35. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139–140 · DOI · Paper page
  36. Gu Z, Gu L, Eils R, Schlesner M, Brors B (2014) circlize Implements and enhances circular visualization in R. Bioinformatics 30:2811–2812 · DOI
  37. Musiek ES, Holtzman DM (2015) Three dimensions of the amyloid hypothesis: time, space and “wingmen.” Nat Neurosci 18:800–806 · DOI · Paper page
  38. Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD et al (2016) Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89:37–53 · DOI · Paper page
  39. Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD (2007) Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci 8:427–437 · DOI
  40. Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, Tian Q et al (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer’s neurodegeneration. Proc Natl Acad Sci U S A 104:3591–3596 · DOI
  41. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N et al (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164–1178 · DOI · Paper page
  42. Chai YL, Chong JR, Raquib AR, Xu X, Hilal S, Venketasubramanian N et al (2021) Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment. Sci Rep 11:4010 · DOI
  43. Selig EE, Zlatic CO, Cox D, Mok YF, Gooley PR, Ecroyd H et al (2020) N- and C-terminal regions of alphaB-crystallin and Hsp27 mediate inhibition of amyloid nucleation, fibril binding, and fibril disaggregation. J Biol Chem 295:9838–9854 · DOI
  44. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer’s disease brains contain 14-3-3 proteins. Neurosci Lett 209:57–60 · DOI
  45. Liang D, Han G, Feng X, Sun J, Duan Y, Lei H (2012) Concerted perturbation observed in a hub network in Alzheimer’s disease. PLoS ONE 7:e40498 · DOI · Paper page
  46. Suo C, Dann E, Goh I, Jardine L, Kleshchevnikov V, Park JE et al. (2022) Mapping the developing human immune system across organs. Science 376:eabo0510 · DOI
  47. Tavares-Ferreira D, Shiers S, Ray PR, Wangzhou A, Jeevakumar V, Sankaranarayanan I, et al. (2022) Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors. Sci Transl Med 14:eabj8186 · DOI

Cited by

Sorted by citations

See all 144

Metadata

Authors
Chen, S., Chang, Y., Li, L., Acosta, D., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C., Julian, D., Hester, M. E., Scharre, D. W., Santiskulvong, C., Song, S. X., Plummer, J. T., Serrano, G. E., Beach, T. G., Duff, K. E., Ma, Q., & Fu, H.
Venue
Acta Neuropathologica Communications
Published
2022-12-21
Volume
10
Issue
1
ISSN
2051-5960
Cited by
144
References
31
Language
en
Funders
  • National Institute on Aging (R01-AG075092-01, K01-AG056673, R56-AG066782-01)
  • National Institute of General Medical Sciences (R01-GM131399)
  • Alzheimer's Association (AARF-17-505009)
  • U.S. Department of Defense (W81XWH1910309)
  • Foundation for the National Institutes of Health (U24-NS072026, P30-AG19610)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review